190 related articles for article (PubMed ID: 221045)
1. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets.
Best LC; McGuire MB; Martin TJ; Preston FE; Russell RG
Biochim Biophys Acta; 1979 Mar; 583(3):344-51. PubMed ID: 221045
[No Abstract] [Full Text] [Related]
2. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
3. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotides in hypertension.
Hamet P; Franks DJ; Adnot S; Coquil JF
Adv Cyclic Nucleotide Res; 1980; 12():11-23. PubMed ID: 6250345
[No Abstract] [Full Text] [Related]
5. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
6. Characterization of thromboxane receptors in human platelets.
Jones RL; Wilson NH; Armstrong RA
Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
[No Abstract] [Full Text] [Related]
7. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
8. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
9. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
Thierauch KH; Gabriel D; Prior G; Schillinger E
Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
[TBL] [Abstract][Full Text] [Related]
10. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
di Minno G; Bertelé V; Bianchi L; Barbieri B; Cerletti C; Dejana E; de Gaetano G; Silver MJ
Thromb Haemost; 1981 Apr; 45(2):103-6. PubMed ID: 6266066
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha.
Armstrong RA; Jones RL; Wilson NH
Prostaglandins; 1985 Apr; 29(4):601-10. PubMed ID: 2988022
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin H2 directly lowers human platelet cAMP levels.
Rybicki JP; Le Breton GC
Thromb Res; 1983 Jun; 30(5):407-14. PubMed ID: 6310815
[TBL] [Abstract][Full Text] [Related]
13. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
14. The cyclic AMP-lowering effect on the stable endoperoxide analog U46619 in human platelets.
Bonne C; Martin B; Regnault F
Thromb Res; 1980 Dec 1-15; 20(5-6):701-4. PubMed ID: 6262941
[No Abstract] [Full Text] [Related]
15. Novel prostaglandin endoperoxide analogs having prostacyclin-like actions on platelets from human and horse but not from rat and rabbit.
Wilson NH; Armstrong RA; Jones RL
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():491-5. PubMed ID: 2821762
[No Abstract] [Full Text] [Related]
16. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
[TBL] [Abstract][Full Text] [Related]
17. The binding of [3H]9,11-dideoxy,9 alpha-11 alpha-methanoepoxy prostaglandin F2 alpha (U 46619) to washed human platelets.
Jaschonek K; Faul C; Weisenberger H; Schmidt H; Renn W
Prog Clin Biol Res; 1989; 301():327-33. PubMed ID: 2529551
[No Abstract] [Full Text] [Related]
18. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.
Miller OV; Johnson RA; Gorman RR
Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153
[TBL] [Abstract][Full Text] [Related]
19. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
Burns GB; Dodge JA
Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
